CAPNOVA (formerly Østjysk Innovation) historically focused on investing state-backed capital in early-stage, innovative startups in Region Midtjylland, particularly those connected to local universities or research institutions. Post-2018, it transitioned to an exit operator role for its legacy portfolio before shifting to a management role for the Midtjysk Iværksætterfond (MIF). Current direct investments are limited to Resother Pharma and Clearview Trade.
Preferred startup development maturity for initial funding deployment.
Early-stage innovative startups with regional (Midtjylland) ties, often linked to academic institutions
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...